Home › Metabolic Disorders › Illinois › Chicago
Metabolic Disorders clinical trials in Chicago, IL
6 studies for Metabolic Disorders are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Chicago
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Chicago
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RecruitingPhase 1/2
- University of Illinois Hospital & Health Sciences System, Chicago
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
RecruitingPhase 1/2
- Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Rare and Atypical Diabetes Network
RecruitingObservational study
- University of Chicago, Chicago
About Metabolic Disorders
Your metabolism makes energy from the food you eat. A metabolic disorder disrupts this process. One example is diabetes. Learn more.
More about Metabolic Disorders on MedlinePlus
Metabolic Disorders trials in other cities
- Washington, DC11 studies
- Ann Arbor, MI8 studies
- St. Louis, MO7 studies
- New York City, NY7 studies
- Durham, NC7 studies
- Baltimore, MD6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Seattle, WA4 studies
- Los Angeles, CA4 studies
- Miami, FL4 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)52 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity42 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.